astilbin has been researched along with Autoimmune Experimental Myasthenia Gravis in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, H; Chen, W; Duan, RS; Li, FF; Li, H; Li, YB; Meng, QF; Sun, SM; Wang, CC; Wang, YJ; Yue, LT; Zhang, CJ; Zhang, M; Zhang, P; Zhang, Z | 1 |
1 other study(ies) available for astilbin and Autoimmune Experimental Myasthenia Gravis
| Article | Year |
|---|---|
Astilbin ameliorates experimental autoimmune myasthenia gravis by decreased Th17 cytokines and up-regulated T regulatory cells.
Topics: Analysis of Variance; Animals; Anti-Inflammatory Agents; Antigens, CD; Body Weight; Cell Proliferation; Cytokines; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Flavonols; Flow Cytometry; HLA-DR alpha-Chains; Myasthenia Gravis, Autoimmune, Experimental; Rats; Rats, Inbred Lew; Sincalide; T-Lymphocytes, Regulatory; Th17 Cells | 2016 |